BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22837709)

  • 1. Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine.
    Mohan S; Fung HL
    Int J Mol Sci; 2012; 13(6):7521-7531. PubMed ID: 22837709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin.
    Topal G; Brunet A; Millanvoye E; Boucher JL; Rendu F; Devynck MA; David-Dufilho M
    Free Radic Biol Med; 2004 Jun; 36(12):1532-41. PubMed ID: 15182855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells.
    Zhu M; Chen J; Tan Z; Wang J
    Anesth Analg; 2012 Feb; 114(2):303-9. PubMed ID: 22156331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study.
    Vásquez-Vivar J; Martásek P; Whitsett J; Joseph J; Kalyanaraman B
    Biochem J; 2002 Mar; 362(Pt 3):733-9. PubMed ID: 11879202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
    Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM
    Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments.
    Yada T; Kaji S; Akasaka T; Mochizuki S; Ogasawara Y; Tanemoto K; Yoshida K; Kajiya F
    Clin Hemorheol Microcirc; 2007; 37(3):269-76. PubMed ID: 17726257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells.
    Mohan S; Wu CC; Shin S; Fung HL
    Amino Acids; 2012 Sep; 43(3):1179-88. PubMed ID: 22130739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells.
    Wells SM; Holian A
    Am J Respir Cell Mol Biol; 2007 May; 36(5):520-8. PubMed ID: 17158357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase.
    Bevers LM; Braam B; Post JA; van Zonneveld AJ; Rabelink TJ; Koomans HA; Verhaar MC; Joles JA
    Hypertension; 2006 Jan; 47(1):87-94. PubMed ID: 16344367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R).
    Perkins KA; Pershad S; Chen Q; McGraw S; Adams JS; Zambrano C; Krass S; Emrich J; Bell B; Iyamu M; Prince C; Kay H; Teng JC; Young LH
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jan; 385(1):27-38. PubMed ID: 21947254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of the extrusion transporter for asymmetric dimethyl-L-arginine: a novel mechanism underlying vasospastic angina.
    Closs EI; Ostad MA; Simon A; Warnholtz A; Jabs A; Habermeier A; Daiber A; Förstermann U; Münzel T
    Biochem Biophys Res Commun; 2012 Jun; 423(2):218-23. PubMed ID: 22609206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia.
    Fabian RH; Perez-Polo JR; Kent TA
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1809-14. PubMed ID: 18676689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of eNOS-derived superoxide by endogenous methylarginines.
    Druhan LJ; Forbes SP; Pope AJ; Chen CA; Zweier JL; Cardounel AJ
    Biochemistry; 2008 Jul; 47(27):7256-63. PubMed ID: 18553936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.
    Mihout F; Shweke N; Bigé N; Jouanneau C; Dussaule JC; Ronco P; Chatziantoniou C; Boffa JJ
    J Pathol; 2011 Jan; 223(1):37-45. PubMed ID: 20845411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.
    Kajimoto H; Kai H; Aoki H; Yasuoka S; Anegawa T; Aoki Y; Ueda S; Okuda S; Imaizumi T
    Kidney Int; 2012 Apr; 81(8):762-8. PubMed ID: 22297680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.